Why Vaccination Does Not Eliminate PCV2 Circulation and How to Improve On-Farm Control

Vaccination against porcine circovirus type 2 (PCV2) has transformed health management in modern swine production, significantly reducing the incidence of clinical disease and improving productive parameters in intensive production herds. However, field experience and scientific evidence show that PCV2 infection has not disappeared. The virus continues to circulate in farms that maintain vaccination against PCV2, demonstrating that although vaccination is an essential tool, it does not always guarantee complete protection against viral transmission.

Immunization against PCV2 aims to activate both humoral and cellular responses in order to limit viral replication and its clinical consequences. When the process is successful, viremia and viral dissemination are reduced. Nevertheless, primary vaccination failures may occur, for example when immunity does not develop due to interference from maternal antibodies, management errors, or problems in administration; and secondary failures, in which protection decreases over time or when facing viral variants with relevant antigenic differences.

Here, the concept of “permeable vaccines” or leaky vaccines becomes relevant. These vaccines do not completely block infection or viral replication, although they do reduce clinical signs. This type of partial immunity allows vaccinated animals to become infected and spread the virus, favoring its persistence within the population. In the case of PCV2d, which presents changes in the capsid protein that may affect recognition by antibodies generated against PCV2a or PCV2b, this situation becomes especially important for on-farm PCV2 control and prevention.

Cross-protection is a critical point in this scenario. Although vaccines developed from PCV2a have shown some efficacy against PCV2d, they do not always neutralize it effectively. Studies have shown that, even in the absence of evident clinical disease, subclinical replication may persist, contributing to constant infection pressure and facilitating coinfections with other respiratory and systemic pathogens.

Controlling viremia is essential not only to protect individual animals, but also to reduce the amount of circulating virus on the farm and its transmission between animals. This requires adjusting vaccination programs to the real epidemiological context of the region and the farm, considering the optimal timing of administration, correct dosing, and the use of diagnostic tools that allow identification of the circulating genotype.

Summary

• Vaccination against PCV2 is essential but not infallible; it may fail against variants or due to management factors.
• Leaky vaccines allow infection and subclinical dissemination, especially with PCV2d.
• Effective control requires adjusting vaccination programs and combining immunization with surveillance and comprehensive management.

References

• Opriessnig T., et al. (2015). Vaccination against porcine circovirus type 2: What works and what does not? Vet. Microbiol.
• Segalés J. (2015). Best practice and future challenges for vaccination against porcine circovirus type 2. Vet. Microbiol.
• Franzo G., et al. (2016). Porcine circovirus type 2 evolution before and after the vaccination introduction: A large scale epidemiological study. Sci. Rep.
• Franzo G., et al. (2020). Porcine circovirus type 2d: epidemiology, genetic diversity and implications for vaccination. Transbound. Emerg. Dis.